The efficacy of cariprazine on function in patients with bipolar depression: a  <i>post hoc</i> analysis of a randomized controlled trial

At week 8, statistically significant improvements in FAST outcomes were observed for cariprazine versus placebo in patients with bipolar I depression; more consistent results were noted for 1.5 mg/d than 3 mg/d. In addition to improving bipolar depression symptoms, these results suggest that cariprazine may improve functional outcomes.